Calculation
P/S | = | Share price1, 2, 3 | ÷ | Sales per share1 | Sales per share1 | = | Revenues1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 22, 2024 | 4.99 | = | 560.49 | ÷ | 112.39 | 112.39 | = | 42,857 | ÷ | 381,312,268 | |
Feb 23, 2023 | 4.73 | = | 550.95 | ÷ | 116.53 | 116.53 | = | 44,915 | ÷ | 385,430,077 | |
Feb 24, 2022 | 5.39 | = | 540.17 | ÷ | 100.23 | 100.23 | = | 39,211 | ÷ | 391,191,770 | |
Feb 25, 2021 | 5.52 | = | 451.47 | ÷ | 81.81 | 81.81 | = | 32,218 | ÷ | 393,793,362 | |
Feb 26, 2020 | 4.83 | = | 309.16 | ÷ | 64.04 | 64.04 | = | 25,542 | ÷ | 398,828,389 | |
Feb 27, 2019 | 4.24 | = | 259.14 | ÷ | 61.05 | 61.05 | = | 24,358 | ÷ | 399,003,681 | |
Feb 28, 2018 | 4.01 | = | 208.58 | ÷ | 52.06 | 52.06 | = | 20,918 | ÷ | 401,784,066 | |
Feb 28, 2017 | 3.37 | = | 157.68 | ÷ | 46.81 | 46.81 | = | 18,274 | ÷ | 390,391,061 | |
Feb 25, 2016 | 3.05 | = | 130.57 | ÷ | 42.81 | 42.81 | = | 16,965 | ÷ | 396,261,928 | |
Feb 26, 2015 | 3.06 | = | 130.14 | ÷ | 42.57 | 42.57 | = | 16,890 | ÷ | 396,782,757 | |
Feb 27, 2014 | 3.74 | = | 124.91 | ÷ | 33.41 | 33.41 | = | 13,090 | ÷ | 391,792,194 | |
Feb 27, 2013 | 2.12 | = | 74.25 | ÷ | 34.98 | 34.98 | = | 12,510 | ÷ | 357,625,034 | |
Feb 29, 2012 | 1.77 | = | 56.62 | ÷ | 32.05 | 32.05 | = | 11,726 | ÷ | 365,853,610 | |
Feb 24, 2011 | 2.00 | = | 55.33 | ÷ | 27.62 | 27.62 | = | 10,789 | ÷ | 390,607,016 | |
Feb 26, 2010 | 1.98 | = | 48.77 | ÷ | 24.69 | 24.69 | = | 10,110 | ÷ | 409,461,414 | |
Feb 27, 2009 | 1.44 | = | 36.26 | ÷ | 25.10 | 25.10 | = | 10,498 | ÷ | 418,164,910 | |
Feb 29, 2008 | 2.40 | = | 55.93 | ÷ | 23.28 | 23.28 | = | 9,746 | ÷ | 418,600,105 | |
Mar 1, 2007 | 5.05 | = | 45.56 | ÷ | 9.03 | 9.03 | = | 3,792 | ÷ | 420,030,996 | |
Mar 2, 2006 | 2.15 | = | 34.78 | ÷ | 16.18 | 16.18 | = | 2,633 | ÷ | 162,738,621 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Thermo Fisher Scientific Inc. Annual Report.
Comparison to Competitors
Thermo Fisher Scientific Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb 22, 2024 | 4.99 | 5.72 | 5.78 | 2.19 | 7.76 | 20.77 | 3.40 | 4.43 | 5.43 | 5.52 | 2.66 | 7.84 |
Feb 23, 2023 | 4.73 | 4.61 | 5.17 | 3.29 | 5.79 | 10.96 | 3.86 | 4.34 | 4.71 | 2.92 | 2.37 | 7.01 |
Feb 24, 2022 | 5.39 | 4.53 | 5.10 | 3.16 | 6.37 | 8.01 | 2.85 | 4.66 | 3.96 | 3.45 | 3.18 | 4.20 |
Feb 25, 2021 | 5.52 | 4.05 | 5.64 | 3.16 | 7.01 | 8.06 | 3.24 | 5.15 | 3.93 | 309.64 | 4.50 | 6.24 |
Feb 26, 2020 | 4.83 | 4.22 | 6.03 | 5.52 | 6.29 | 6.03 | 4.00 | 4.79 | 4.33 | — | 3.66 | 5.34 |
Feb 27, 2019 | 4.24 | 3.58 | 5.22 | 3.67 | 3.97 | 5.15 | 3.84 | 4.45 | 4.92 | — | 4.49 | 6.62 |
Feb 28, 2018 | 4.01 | 6.67 | 5.82 | 5.02 | 3.70 | 3.71 | 4.10 | 4.56 | 3.68 | — | 4.05 | 5.92 |
Feb 28, 2017 | 3.37 | 3.84 | 5.65 | 4.72 | 3.48 | 4.18 | 3.08 | 4.62 | 4.54 | — | 3.84 | 7.86 |
Feb 25, 2016 | 3.05 | 3.83 | 5.28 | 6.07 | 2.91 | 4.02 | 3.80 | 4.13 | 3.56 | — | 3.76 | 9.38 |
Feb 26, 2015 | 3.06 | 4.90 | 6.13 | 6.28 | 3.09 | 4.03 | 6.36 | 3.77 | 3.93 | — | 4.24 | 14.62 |
Feb 27, 2014 | 3.74 | 4.31 | 5.22 | 5.48 | 2.78 | 2.81 | 11.95 | 3.63 | 3.78 | — | 3.97 | 15.52 |
Feb 27, 2013 | 2.12 | 3.30 | 4.09 | 3.40 | 2.32 | 2.71 | 6.95 | 3.17 | 2.73 | — | 3.34 | 11.66 |
Feb 29, 2012 | 1.77 | — | 3.52 | 2.63 | 2.28 | 1.87 | 4.22 | 2.75 | 2.43 | — | 2.37 | 20.90 |
Feb 24, 2011 | 2.00 | — | 3.32 | 2.23 | 2.48 | 1.73 | 4.19 | 2.65 | 2.18 | — | 2.27 | 7.38 |
Feb 26, 2010 | 1.98 | — | 3.88 | 2.27 | 2.16 | 1.82 | 6.64 | 2.82 | 4.23 | — | 2.83 | 5.74 |
Feb 27, 2009 | 1.44 | — | 3.44 | 1.96 | 1.30 | 1.66 | 8.03 | 2.37 | 2.14 | — | 1.72 | 5.17 |
Feb 29, 2008 | 2.40 | — | 3.46 | 2.30 | 2.16 | 3.05 | 10.90 | 2.95 | 4.04 | — | 3.11 | 11.94 |
Mar 1, 2007 | 5.05 | — | 5.41 | 3.07 | 2.30 | 3.80 | 12.67 | 3.53 | 4.23 | — | 3.67 | 19.70 |
Mar 2, 2006 | 2.15 | — | 7.24 | 2.34 | 2.40 | 4.31 | 15.36 | 3.49 | 3.50 | — | 3.77 | 14.06 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Thermo Fisher Scientific Inc., P/S, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
Thermo Fisher Scientific Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
---|---|---|
Feb 22, 2024 | 4.99 | 5.78 |
Feb 23, 2023 | 4.73 | 4.44 |
Feb 24, 2022 | 5.39 | 4.42 |
Feb 25, 2021 | 5.52 | 5.00 |
Feb 26, 2020 | 4.83 | 4.79 |
Feb 27, 2019 | 4.24 | 4.46 |
Feb 28, 2018 | 4.01 | 4.51 |
Feb 28, 2017 | 3.37 | 4.24 |
Feb 25, 2016 | 3.05 | 4.05 |
Feb 26, 2015 | 3.06 | 4.46 |
Feb 27, 2014 | 3.74 | 4.25 |
Feb 27, 2013 | 2.12 | 3.24 |
Feb 29, 2012 | 1.77 | 2.56 |
Feb 24, 2011 | 2.00 | 2.41 |
Feb 26, 2010 | 1.98 | 2.96 |
Feb 27, 2009 | 1.44 | 2.20 |
Feb 29, 2008 | 2.40 | 3.18 |
Mar 1, 2007 | 5.05 | 3.87 |
Mar 2, 2006 | 2.15 | 3.82 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Thermo Fisher Scientific Inc. | Health Care | |
---|---|---|
Feb 22, 2024 | 4.99 | 2.30 |
Feb 23, 2023 | 4.73 | 33,191.58 |
Feb 24, 2022 | 5.39 | 2.28 |
Feb 25, 2021 | 5.52 | 2.25 |
Feb 26, 2020 | 4.83 | 2.13 |
Feb 27, 2019 | 4.24 | 2.33 |
Feb 28, 2018 | 4.01 | 2.30 |
Feb 28, 2017 | 3.37 | 2.12 |
Feb 25, 2016 | 3.05 | 2.10 |
Feb 26, 2015 | 3.06 | 2.38 |
Feb 27, 2014 | 3.74 | 2.17 |
Feb 27, 2013 | 2.12 | 1.73 |
Feb 29, 2012 | 1.77 | 1.55 |
Feb 24, 2011 | 2.00 | 1.46 |
Feb 26, 2010 | 1.98 | 1.64 |
Feb 27, 2009 | 1.44 | 1.36 |
Feb 29, 2008 | 2.40 | 2.01 |
Mar 1, 2007 | 5.05 | 2.43 |
Mar 2, 2006 | 2.15 | 2.72 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).